U.S. stocks fell on Tuesday as investors locked in profits from a post-election rally and awaited inflation data. Concerns ...
Biotech firm Novavax dropped 9.1% after cutting its annual revenue forecast due to lower-than-expected sales of its COVID-19 ...
Biotech firm Novavax dropped after cutting its annual revenue forecast due to lower-than-expected sales of its COVID-19 ...
Wall Street's main indexes fell on Tuesday as investors booked profits from post-election gains and awaited U.S. inflation ...
Novavax, a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, is proud to announce an exciting new partnership with the Los Angeles Rams aimed at "Protecting the Rams House" ...
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...
Hosted on MSN9h
Wall Street dips as focus moves to economic data(Reuters) -Wall Street's main indexes fell on Tuesday as investors booked profits following post-election gains over the past ...
Good morning and welcome to Novavax' Third Quarter 2024 Financial Results and Operational ... Sanofi will take the lead co-commercialization role for our COVID-19 vaccine starting in 2025, enabling us ...
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...
Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback